Phenotypic Drug Discovery Topical Interest Group (TIG)

 View Only

Marc Bickle (Roche), Chair

The phenotypic drug discovery (PDD) SIG will serve as a discussion forum for the global research community to share/discuss/debate topics related to PDD research. Participants will share their experiences, perceptions, and thoughts on the advantages/disadvantages of PDD and whether/how PDD complements targeted drug discovery (TDD) strategies. Related topics such as target identification/validation, chemical diversity, chemical genomics, chemo-informatics, poly-pharmacology, translational pharmacology, biological model systems and patient tailoring are also in scope.

Latest Discussions

Please login to see recent discussions.

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Announcements

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Latest Library Entries

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Most Active